Final Results from the Phase 2 REVIVE Study Investigating the Hepcidin Mimetic Rusfertide in Patients with Polycythemia Vera (PV) Gerds A, et al
66th American Society of Hematology (ASH) Annual Meeting and Exposition
calendar_today
December 7, 2024
domain
protagonist-therapeutics